[This corrects the article DOI: 10.1371/journal.pone.0004264.].
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6752793 | PMC |
| http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0223041 | PLOS |
Publication Analysis
Top Keywords
Similar Publications
Correction: The LKB1-TSSK1B axis controls YAP phosphorylation to regulate the Hippo-YAP pathway.
Cell Death Dis
November 2024
Department of Biomedical Sciences, Graduate School, Ajou University School of Medicine, Suwon, 16499, South Korea.
STK11 (LKB1) immunohistochemistry is a sensitive and specific marker for STK11 adnexal tumours.
Histopathology
November 2024
Division of Women's and Perinatal Pathology, Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Article Synopsis
- - STK11 adnexal tumours are rare malignant neoplasms associated with Peutz-Jeghers syndrome, primarily arising from para-adnexal soft tissues and potentially affecting the fallopian tube and ovary; diagnosis currently involves identifying STK11 mutations.
- - Researchers conducted immunohistochemistry (IHC) on 122 tumours, including 17 STK11 adnexal tumours and 105 lookalikes; results showed that STK11 adnexal tumours had complete loss of STK11 protein expression, while other tumour types generally retained it.
- - The study concludes that STK11 serves as a sensitive and specific marker for distinguishing STK11 adnexal tumours
Correction: MALAT1/ mir-1-3p mediated BRF2 expression promotes HCC progression via inhibiting the LKB1/AMPK signaling pathway.
Cancer Cell Int
July 2024
Department of General Surgery, Qilu Hospital of Shandong University, 107 West Wen Hua Road, Jinan, 250012, China.
Nrf2 prevents diabetic cardiomyopathy via antioxidant effect and normalization of glucose and lipid metabolism in the heart.
J Cell Physiol
February 2024
Key Laboratory of Pathobiology, Ministry of Education, College of Basic Medical Sciences, Jilin University, Changchun, Jilin, China.
Metabolic disorders and oxidative stress are the main causes of diabetic cardiomyopathy. Activation of nuclear factor erythroid 2-related factor 2 (Nrf2) exerts a powerful antioxidant effect and prevents the progression of diabetic cardiomyopathy. However, the mechanism of its cardiac protection and direct action on cardiomyocytes are not well understood.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!